FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1242215 · Received November 19, 2008

Report

Report Number
2024168-2008-01172
Event Type
Injury
Date Received
November 19, 2008
Date of Event
October 1, 2008
Report Date
October 24, 2008
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE SECOND XIENCE V (PART# 1009551-18/LOT# 70227P5) IS BEING FILED UNDER THE SAME MFR NUMBER. RESULTS AND CONCLUSION SUMMATION - PRODUCT PERFORMANCE ENGINEERING REVIEWED THE INCIDENT. ANGINA, AS LISTED IN THE INSTRUCTIONS FOR USE AND PRODUCT RISK ASSESSMENT (RAM), IS A KNOWN RISK ASSOCIATED WITH CORONARY STENTING. DIAPHORESIS (SWEATING) AND HOSPITALIZATION ARE LISTED IN THE RAM AS NO-FAULT POST-PROCEDURE COMPLICATIONS. THERE DOES NOT APPEAR TO BE ANY INDICATIONS OF A STENT DELIVERY SYSTEM QUALITY PROBLEM. A CONCLUSIVE ROOT CAUSE FOR THE REPORTED PT ISSUES, AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED.

Description of Event or Problem · 1

REPORTING STATUS: SERIOUS INJURY. REPORTING RATIONALE: PT REQUIRED MEDICAL INTERVENTION. DEVICE ISSUE: NO DEVICE MALFUNCTION HAS BEEN REPORTED. IT WAS REPORTED VIA A TRIAL THAT APPROX 14 MOS AFTER THE TWO 2.5X18MM XIENCE V STENTS WERE IMPLANTED, THE PT EXPERIENCED ANGINA, NAUSEA AND DIAPHORESIS (SWEATING). A DIAGNOSTIC CORONARY ANGIOGRAPHY WAS DONE AND REVASCULARIZATION WAS PERFORMED AND A PROMUS STENT WAS PLACED IN THE DISTAL LAD. NO ADD'L EVENT OR PT INFO IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA 70227P5

Patients

Seq Age Sex Outcome Treatment
1 58 YR Hospitalization| R XIENCE V 2.5X18MM (PART# 1009551-18/LOT# 70227P5)